Press Releases
Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care
PRNewswire | 11 hours 2 minutes ago
... (more)
DX-88 (ecallantide) Demonstrated Relief of Symptoms in Hereditary Angioedema Acute Attacks in All Attack Locations
Business Wire | 11 hours 2 minutes ago
An analysis demonstrating the ability of DX-88 (ecallantide) to resolve symptoms of acute hereditary angioedema (HAE) attacks in all anatomic locations and to sustain effect will be presented in an oral presentation this week at the American College of Allergy, Asthma and Immunology (ACAAI) 2009 Annual Meeting in Miami Beach. This evaluation, and two others to be presented, highlight efficacy and safety analyses from the integrated analysis of the two Phase 3 placebo-controlled trials, EDEMA3...... (more)
Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity
PRNewswire | 11 hours 2 minutes ago
... (more)
GlaxoSmithKline and XenoPort Announce Extension of GSK1838262 (XP13512) FDA Review Date to February 9, 2010
Business Wire | 21 hours 32 minutes ago
GlaxoSmithKline (NYSE: GSK) and XenoPort, Inc. (Nasdaq: XNPT) today announced that the U.S. Food and Drug Administration (FDA) has extended the original Prescription Drug User Fee Act (PDUFA) goal date for its review of the New Drug Application (NDA) for GSK1838262/XP13512 (gabapentin enacarbil) to February 9, 2010. The original PDUFA date for this NDA review was November 9, 2009.... (more)
Zacks Analyst Blog Highlights: Ambercrombie & Fitch Co., Costco, Target, Walgreen Co. and Rite Aid
Business Wire | 1 day 1 hour 1 minute ago
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Ambercrombie & Fitch Co. (NYSE: ANF), Costco (Nasdaq: COST), Target (NYSE: TGT), Walgreen Co. (NYSE: WAG) and Rite Aid (NYSE: RAD).... (more)
Celgene Corporation to Present at Two Upcoming Investor Conferences
Business Wire | 1 day 1 hour 31 minutes ago
Celgene Corporation (NASDAQ: CELG) today announced its presentations at two upcoming investor conferences will be webcast live and will be available in the investor relations section of the company’s Web site at www.celgene.com. Celgene management will provide an overview of the company.... (more)
Stratus Properties Inc. Reports Third-Quarter and Nine-Month 2009 Results and Updates W Austin Hotel & Residences Development Activities
Business Wire | 1 day 1 hour 31 minutes ago
Stratus Properties Inc. (NASDAQ: STRS):... (more)
Covidien Completes Acquisition of Aspect Medical Systems Inc.
Business Wire | 1 day 1 hour 31 minutes ago
Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of Aspect Medical Systems Inc. for an aggregate consideration of approximately $210 million, net of cash and short-term investments acquired.... (more)
Celsion to Hold Third Quarter 2009 Financial Results Conference Call Tuesday, November 10, 2009
Business Wire | 1 day 3 hours 2 minutes ago
Celsion Corporation (NASDAQ:CLSN), a late stage clinical oncology development company that is leveraging its heat activated liposomal technology platform to encapsulate and deliver high concentrations of proven chemotherapeutics, today announced that it will hold a conference call to discuss third quarter 2009 results at 11:00 a.m. Eastern Time on Tuesday, November 10, 2009. To participate in the call, interested parties may dial 1-877-852-6580 or 1-719-325-4751 (International) and use Confer...... (more)
CEL-SCI's L.E.A.P.S. H1N1 Flu Development Seen as Credibility Booster
Business Wire | 1 day 5 hours 2 minutes ago
BioMedReports.com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, reports that one of several expected key news developments has been announced by CEL-SCI Corporation (NYSE Amex: CVM), today.... (more)
SURGICAL INNOVATIONS GROUP PLC - Director/PDMR Shareholding
PRNewswire | 1 day 7 hours 1 minute ago
SURGICAL INNOVATIONS GROUP PLC DIRECTOR / PDMR SHAREHOLDING ... (more)
Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution
PRNewswire | 1 day 7 hours 2 minutes ago
... (more)
Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting
PRNewswire | 1 day 9 hours 1 minute ago
CALGARY, Nov. 6 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ... (more)
Graceway Pharmaceuticals Acquires Worldwide Rights to GS 9191 from Gilead Sciences
Business Wire | 1 day 9 hours 1 minute ago
Graceway Pharmaceuticals, LLC, a portfolio company of GTCR Golder Rauner, LLC, today announced that the company has acquired from Gilead Sciences, Inc. the worldwide license, including related regulatory filings and intellectual properties, to Gilead’s investigational molecule, GS 9191, for topical use. GS 9191 is an anti-proliferative agent that works by inhibiting cellular DNA synthesis, leading to the induction of apoptosis, or programmed cell death.... (more)
87 Press Releases | 
RSS Feed
Sign up for ANA SmartBrief
Companies in the news
- Affymax Inc.
- Antigenics, Inc.
- AtriCure Inc.
- Exelixis Inc
- GenVec, Inc.
- Genzyme
- HCA Inc.
- IVAX Pharmaceuticals
- Nobel Biocare Holding AG
- Psychiatric Solutions
- RehabCare Group Inc.
- Syneron Medical Ltd.
- Tenet Healthcare Corp.
- Teva Pharmaceutical Industries
- Watson Pharmaceuticals